Stock Groups

Merck KGaA lifts FY guidance on surging demand for lab supplies -Breaking

by Mike Robinson

[ad_1]

2/2
© Reuters. FILE PHOTO – A Merck KGaA logo is pictured in Darmstadt (Germany), January 28, 2016. REUTERS/Ralph Orlowski/File photo

2/2

FRANKFURT (Reuters – Germany’s Merck KGaA lifted its full year profit forecast on Wednesday, citing a strong performance in its Life Science unit. This supplies gear and materials to COVID-19 manufacturers and other pharmaceutical companies.

Unscheduled statements were made by the diversified group. They stated that 2021 earnings before interest taxes, depreciation, and amortization (EBITDA) will be 6 billion to 6.33 billion Euros ($7.4 billion to $7.3 Billion). This is an increase of 5.2billion in 2020.

It had previously targeted 5.6 billion to 6 billion euros.

($1 = 0.8633 euros)

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, futures, indexes and Forex. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]